• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Proc Natl Acad Sci U S A . Thiol-based chemical probes exhibit antiviral activity against SARS-CoV-2 via allosteric disulfide disruption in the spik

tetano

Editor, Senior Moderator
Proc Natl Acad Sci U S A


. 2022 Feb 8;119(6):e2120419119.
doi: 10.1073/pnas.2120419119.
Thiol-based chemical probes exhibit antiviral activity against SARS-CoV-2 via allosteric disulfide disruption in the spike glycoprotein


Yunlong Shi[SUP] 1 [/SUP], Ari Zeida[SUP] 2 [/SUP], Caitlin E Edwards[SUP] 3 [/SUP], Michael L Mallory[SUP] 3 [/SUP], Santiago Sastre[SUP] 2 [/SUP], Matías R Machado[SUP] 4 [/SUP], Raymond J Pickles[SUP] 5 6 [/SUP], Ling Fu[SUP] 7 [/SUP], Keke Liu[SUP] 7 [/SUP], Jing Yang[SUP] 7 [/SUP], Ralph S Baric[SUP] 3 [/SUP], Richard C Boucher[SUP] 8 [/SUP], Rafael Radi[SUP] 9 [/SUP], Kate S Carroll[SUP] 10 [/SUP]



Affiliations

Abstract

The development of small-molecules targeting different components of SARS-CoV-2 is a key strategy to complement antibody-based treatments and vaccination campaigns in managing the COVID-19 pandemic. Here, we show that two thiol-based chemical probes that act as reducing agents, P2119 and P2165, inhibit infection by human coronaviruses, including SARS-CoV-2, and decrease the binding of spike glycoprotein to its receptor, the angiotensin-converting enzyme 2 (ACE2). Proteomics and reactive cysteine profiling link the antiviral activity to the reduction of key disulfides, specifically by disruption of the Cys379-Cys432 and Cys391-Cys525 pairs distal to the receptor binding motif in the receptor binding domain (RBD) of the spike glycoprotein. Computational analyses provide insight into conformation changes that occur when these disulfides break or form, consistent with an allosteric role, and indicate that P2119/P2165 target a conserved hydrophobic binding pocket in the RBD with the benzyl thiol-reducing moiety pointed directly toward Cys432. These collective findings establish the vulnerability of human coronaviruses to thiol-based chemical probes and lay the groundwork for developing compounds of this class, as a strategy to inhibit the SARS-CoV-2 infection by shifting the spike glycoprotein redox scaffold.

Keywords: SARS-CoV-2; disulfide bonds; redox biology; spike glycoprotein; thiol-based chemical probes.
 
Back
Top Bottom